KALEIDO Trademark

Trademark Overview


On Friday, October 9, 2015, a trademark application was filed for KALEIDO with the United States Patent and Trademark Office. The USPTO has given the KALEIDO trademark a serial number of 86783357. The federal status of this trademark filing is REGISTERED as of Tuesday, December 17, 2019. This trademark is owned by VL32, Inc.. The KALEIDO trademark is filed in the Pharmaceutical Products category with the following description:

preparations and substances for pharmaceutical and medical purposes, namely, for the treatment of dysbioses, inflammatory disorders and conditions, infectious diseases, metabolic diseases, nutritional disorders, malnutrition, immune-mediated diseases, including autoimmune diseases, allergies, and immune tolerance, malignancies and cancers, neurological diseases, psychiatric conditions, gastrointestinal diseases and disorders, gastrointestinal injury conditions, digestive abnormalities, dermatological conditions, cardiovascular diseases, nephrologic diseases and conditions, including organ failure, ophthalmic disorders, vaginal and penile conditions, pediatric disorders and conditions, including growth and developmental conditions, and geriatric disorders and conditions, all of the foregoing related to the microbiome and all of the foregoing excluding treatments for cystic fibrosis; therapeutic pharmaceuticals for medical use, namely, for the treatment of dysbioses, inflammatory disorde...
kaleido

General Information


Serial Number86783357
Word MarkKALEIDO
Filing DateFriday, October 9, 2015
Status700 - REGISTERED
Status DateTuesday, December 17, 2019
Registration Number5938245
Registration DateTuesday, December 17, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 28, 2018

Trademark Statements


Goods and Servicespreparations and substances for pharmaceutical and medical purposes, namely, for the treatment of dysbioses, inflammatory disorders and conditions, infectious diseases, metabolic diseases, nutritional disorders, malnutrition, immune-mediated diseases, including autoimmune diseases, allergies, and immune tolerance, malignancies and cancers, neurological diseases, psychiatric conditions, gastrointestinal diseases and disorders, gastrointestinal injury conditions, digestive abnormalities, dermatological conditions, cardiovascular diseases, nephrologic diseases and conditions, including organ failure, ophthalmic disorders, vaginal and penile conditions, pediatric disorders and conditions, including growth and developmental conditions, and geriatric disorders and conditions, all of the foregoing related to the microbiome and all of the foregoing excluding treatments for cystic fibrosis; therapeutic pharmaceuticals for medical use, namely, for the treatment of dysbioses, inflammatory disorders and conditions, infectious diseases, metabolic diseases, nutritional disorders, malnutrition, immune-mediated diseases, including autoimmune diseases, allergies, and immune tolerance, malignancies and cancers, neurological diseases, psychiatric conditions, gastrointestinal diseases and disorders, gastrointestinal injury conditions, digestive abnormalities, dermatological conditions, cardiovascular diseases, nephrologic diseases and conditions, including organ failure, ophthalmic disorders, vaginal and penile conditions, pediatric disorders and conditions, including growth and developmental conditions, and geriatric disorders and conditions, all of the foregoing related to the microbiome and all of the foregoing excluding treatments for cystic fibrosis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 9, 2016
Primary Code005
First Use Anywhere DateWednesday, July 31, 2019
First Use In Commerce DateWednesday, July 31, 2019

Trademark Owner History


Party NameKALEIDO BIOSCIENCES, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Party NameKALEIDO BIOSCIENCES, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Party NameKALEIDO BIOSCIENCES, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressBEDFORD, MA 01730

Party NameVL32, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Tuesday, December 17, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, November 13, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 12, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, November 4, 2019STATEMENT OF USE PROCESSING COMPLETE
Friday, October 18, 2019USE AMENDMENT FILED
Saturday, November 2, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, October 18, 2019TEAS STATEMENT OF USE RECEIVED
Thursday, April 25, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 23, 2019EXTENSION 1 GRANTED
Tuesday, April 23, 2019EXTENSION 1 FILED
Tuesday, April 23, 2019TEAS EXTENSION RECEIVED
Wednesday, January 2, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, January 2, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 23, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 28, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 28, 2018PUBLISHED FOR OPPOSITION
Wednesday, August 8, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 25, 2018EXPARTE APPEAL TERMINATED
Wednesday, July 25, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 24, 2018ASSIGNED TO EXAMINER
Tuesday, July 24, 2018JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, September 26, 2017NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Tuesday, September 26, 2017ACTION DENYING REQ FOR RECON E-MAILED
Tuesday, September 26, 2017ACTION CONTINUING FINAL - COMPLETED
Wednesday, September 20, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 20, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 13, 2017ASSIGNED TO LIE
Wednesday, September 6, 2017TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, September 6, 2017EX PARTE APPEAL-INSTITUTED
Wednesday, September 6, 2017JURISDICTION RESTORED TO EXAMINING ATTORNEY
Wednesday, September 6, 2017EXPARTE APPEAL RECEIVED AT TTAB
Wednesday, March 8, 2017NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, March 8, 2017FINAL REFUSAL E-MAILED
Wednesday, March 8, 2017FINAL REFUSAL WRITTEN
Wednesday, February 22, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, February 16, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 16, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 16, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 24, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 24, 2016NON-FINAL ACTION E-MAILED
Wednesday, August 24, 2016NON-FINAL ACTION WRITTEN
Tuesday, August 9, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 8, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 8, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 8, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 8, 2016NON-FINAL ACTION E-MAILED
Monday, February 8, 2016NON-FINAL ACTION WRITTEN
Monday, February 1, 2016ASSIGNED TO EXAMINER
Thursday, October 15, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM